Bristol-Myers Squibb Company,   USA

Abilifay®
Antipsychotic agent (antipsychotic)
Solution for intramuscular injection 7.5 mg / ml.
Abilifay®
Antipsychotic agent (antipsychotic)
Tablets 5 mg, 10 mg, 15 mg, 30 mg.
Videx®
Antiviral (HIV) agent
Capsules intestine soluble 125 mg, 250 mg and 400 mg.
Videx®
Antiviral (HIV) agent
Powder for solution for oral administration 2 g.
Daklinsa®
Antiviral agent
Film coated tablets, 30 and 60 mg.
Ervoi®
antitumor agent - antibodies monoclonal

Solution for infusion, 5 mg / ml.

Zerit®
antiviral (HIV) agent
Powder for solution for oral administration, 1 mg / ml
To 12.6 g of powder into a 260 ml high-pressure polyethylene bottle (for obtaining 200 ml of oral solution), with a neck sealed with a foil with the BMS logo, sealed with a screwed polypropylene cover that can not be opened by children. The bottle cap is marked with two arrows and the inscriptions "Close tightly" and "While pushing down turn". One bottle in a set with a measuring cap and instructions for medical use in a cardboard box.

Maxipim®
Antibiotic-cephalosporin.
Powder for the preparation of solution for intravenous and intramuscular injection of 500 mg and 1000 mg.


Opportunity®
Antineoplastic agent, monoclonal antibodies

Concentrate for solution for infusion, 10 mg / ml.

Orencia®
Immunosuppressive remedy

Solution for subcutaneous administration 125 mg / ml.

Orencia®
Immunosuppressive remedy

Lyophilizate for the preparation of a solution for infusions 250 mg.

Reatase®
Antiviral [HIV] agent
Capsules 150 mg, 200 mg.
Reatase®
Antiviral [HIV] agent
Capsules 150 mg, 200 mg, 300 mg.
Spiceel®
antitumor agent - protein tyrosine kinase inhibitor.

Tablets, film-coated 20 mg, 50 mg, 70 mg.

Sunwapra ™
Antiviral agent

Capsules soft 100 mg.

Elikvis®
Anticoagulant direct action is a selective inhibitor of the coagulation factor Ha (FXa).
Tablets, film-coated, 2.5 mg.

Elikvis®
Anticoagulant direct action is a selective inhibitor of the coagulation factor Ha (FXa).
Tablets, film-coated, 5 mg.
Emplicity®
Antineoplastic agent, monoclonal antibodies

Lyophilizate for the preparation of concentrate for the preparation of a solution for infusions 300 mg, 400 mg.